These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 32459564)

  • 1. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance Therapy of Psychosis Spectrum Disorders in a Real-World Setting: Antipsychotics Prescription Patterns and Long-Term Benzodiazepine Use.
    Maric NP; Andric Petrovic S; Russo M; Jerotic S; Ristic I; Savić B; Pemovska T; Milutinovic M; Ribic E; Markovska-Simoska S; Dzubur Kulenovic A; Jovanovic N
    Front Psychiatry; 2022; 13():796719. PubMed ID: 35463504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.
    Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HFK; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Avasthi A; Grover S; Ng CH; Ungvari GS; Xiang YT
    Asian J Psychiatr; 2019 Oct; 45():74-80. PubMed ID: 31520884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.
    Grover S; Naskar C; Chakrabarti S
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):148-154. PubMed ID: 33666401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study.
    Hashimoto Y; Tensho M
    BMC Health Serv Res; 2016 Apr; 16():150. PubMed ID: 27117589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
    Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
    Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Benzodiazepine Prescription During Maintenance Therapy of Individuals With Psychosis Spectrum Disorders-Associations With Cognition and Global Functioning.
    Savić B; Jerotić S; Ristić I; Zebić M; Jovanović N; Russo M; Marić NP
    Clin Neuropharmacol; 2021 May-Jun 01; 44(3):89-93. PubMed ID: 33560008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting.
    Julaeha J; Athiyah U; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ethnicity on prescribing practice and treatment outcome in inpatients suffering from schizophrenia in Greece.
    Douzenis A; Apostolopoulos A; Seretis D; Rizos EN; Christodoulou C; Lykouras L
    BMC Psychiatry; 2011 Apr; 11():66. PubMed ID: 21507225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social and clinical descriptors of antipsychotic prescription.
    Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; de Ponti F
    Int J Psychiatry Med; 2015; 49(1):45-62. PubMed ID: 25838320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
    BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.
    Chong MY; Tan CH; Fujii S; Yang SY; Ungvari GS; Si T; Chung EK; Sim K; Tsang HY; Shinfuku N
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):61-7. PubMed ID: 14678459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.
    Correll CU; Gallego JA
    Psychiatr Clin North Am; 2012 Sep; 35(3):661-81. PubMed ID: 22929872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic polypharmacy in schizophrenia: benefits and risks.
    Barnes TR; Paton C
    CNS Drugs; 2011 May; 25(5):383-99. PubMed ID: 21476610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant prescription patterns and polypharmacy in outpatient psychiatry: a cross-sectional study.
    Al Zaabi MSR; Sridhar SB; Rabbani SA; Tadross TM; Shareef J; Shariff A
    Pharmazie; 2024 May; 79(3):82-90. PubMed ID: 38872268
    [No Abstract]   [Full Text] [Related]  

  • 18. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.
    Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):572-579. PubMed ID: 29761577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care.
    Hoyle DJ; Peterson GM; Bindoff IK; Clinnick LM; Bindoff AD; Breen JL
    Int Psychogeriatr; 2021 Jun; 33(6):587-599. PubMed ID: 32618535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.